EUVIMEDEUVIMED entdecken
Open Access

Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection

Ang Gao, Yunsheng Chen, Hui Liang, Xinyuan Cui, Amin Zhang, Daxiang Cui

Theranostics · 2023

DOI: 10.7150/thno.83390 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2023. Verfasst von Ang Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Instrument for Diagnosis and Therapy, School of S…. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19, SARS-CoV-2, Th1 Cells. Die Arbeit wurde bisher 13-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19SARS-CoV-2Th1 CellsAnimalsMiceSpike Glycoprotein, CoronavirusGraphiteAntibodies, ViralAdjuvants, ImmunologicFemaleNeedlesAdjuvants, VaccineHumansOligodeoxyribonucleotidesVaccinationNanoparticlesMice, Inbred BALB CCD8-Positive T-LymphocytesImmunoglobulin GVaccines, SubunitImmunity, CellularNanovaccines

Stichwörter der Autor:innen

RBD-specific Type 1 cellular responseReceptor-Binding Domaingraphene oxidemicroneedle patchnanovaccine

Substanzen

COVID-19 VaccinesSpike Glycoprotein, CoronavirusGraphitespike protein, SARS-CoV-2Antibodies, ViralAdjuvants, Immunologicgraphene oxideAdjuvants, VaccineOligodeoxyribonucleotidesImmunoglobulin G

Autor:innen und Institutionen

  • Institute of Nano Biomedicine and Engineering, Shanghai Engineering Research Center for Intelligent Instrument for Diagnosis and Therapy, School of Sensing Science and Engineering, Shanghai Jiao Tong University, Shangha…
  • National Engineering Research Center for Nanotechnology, 28 East Jiangchuan Road, Shanghai 200241, China.
  • Radiology Department of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, 197 Ruijin Second Road, Shanghai 200025, China.

Zitieren

APA

Gao, A., Chen, Y., Liang, H., Cui, X., Zhang, A., & Cui, D. (2023). Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection. Theranostics. https://doi.org/10.7150/thno.83390

Vancouver

Gao A, Chen Y, Liang H, Cui X, Zhang A, Cui D. Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection. Theranostics. 2023. doi:10.7150/thno.83390

BibTeX
@article{Gao2023,
  author = {Gao, Ang and Chen, Yunsheng and Liang, Hui and Cui, Xinyuan and Zhang, Amin and Cui, Daxiang},
  title = {Developing an efficient MGCR microneedle nanovaccine patch for eliciting Th 1 cellular response against the SARS-CoV-2 infection},
  journal = {Theranostics},
  year = {2023},
  doi = {10.7150/thno.83390}
}
Kostenlos starten →